{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:46Z","timestamp":1786118986674,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/mop.0b013e32830d3aaf","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T03:09:19Z","timestamp":1220929759000},"page":"566-570","source":"Crossref","is-referenced-by-count":14,"title":["Laboratory evaluation of inflammatory bowel disease"],"prefix":"10.1097","volume":"20","author":[{"given":"Allison","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsey","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210206","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1067\/S0022-3476(03)00444-X","article-title":"Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study","volume":"143","author":"Kugathasan","year":"2003","journal-title":"J Pediatr"},{"key":"R2-9-20210206","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1542\/peds.2006-1865","article-title":"Laboratory values for children with newly diagnosed inflammatory bowel disease","volume":"119","author":"Mack","year":"2007","journal-title":"Pediatrics"},{"key":"R3-9-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/2008\/974540","article-title":"Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis","volume":"22","author":"Anand","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"R4-9-20210206","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1572-0241.2004.40369.x","article-title":"Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype","volume":"99","author":"Zholudev","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R5-9-20210206","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000109928","article-title":"Diagnostic value of serological assays in pediatric inflammatory bowel disease","volume":"75","author":"Mainardi","year":"2007","journal-title":"Digestion"},{"key":"R6-9-20210206","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3748\/wjg.v13.i16.2312","article-title":"Update on anti-Saccharomyces cerevisiae antibodies, antinuclear associated antineutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study","volume":"13","author":"Desplat-Jego","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R7-9-20210206","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MPG.0b013e31812f7f6e","article-title":"Antibodies to Eschericia coli outer membrane porin c in the absence of anti-Saccharomyces cerevisiae antibodies and antineutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis","volume":"45","author":"Davis","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R8-9-20210206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1542\/peds.2006-1361","article-title":"Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia","volume":"119","author":"Sabery","year":"2007","journal-title":"Pediatrics"},{"key":"R9-9-20210206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2007.02.025","article-title":"Enzymes in feces: useful markers of chronic inflammatory bowel disease","volume":"381","author":"Angriman","year":"2007","journal-title":"Clinica Chimica Acta"},{"key":"R10-9-20210206","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ibd.20275","article-title":"Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies","volume":"14","author":"Schoepfer","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R11-9-20210206","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ibd.20336","article-title":"Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children","volume":"14","author":"Sidler","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R12-9-20210206","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","article-title":"Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy","volume":"102","author":"von Roon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R13-9-20210206","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MPG.0b013e31810e75a9","article-title":"Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease","volume":"45","author":"Fagerberg","year":"2007","journal-title":"J Pediat Gastroenterol Nutr"},{"key":"R14-9-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices","volume":"103","author":"Langhorst","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R15-9-20210206","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ibd.20376","article-title":"Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease","volume":"5","author":"Walkiewicz","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R16-9-20210206","first-page":"1","article-title":"Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel disease","volume":"13","author":"Diamanti","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R17-9-20210206","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MPG.0b013e3180308d8e","article-title":"Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease","volume":"44","author":"Walker","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl 1","key":"R18-9-20210206","first-page":"S30","article-title":"Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD","volume":"3","author":"Seidman","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"R19-9-20210206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-200746030-00001","article-title":"Thiopurine treatment in inflammatory bowel disease","volume":"46","author":"Teml","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R20-9-20210206","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2036.2007.03278.x","article-title":"Thiopurine metabolite monitoring in pediatric inflammatory bowel disease","volume":"25","author":"Ooi","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-9-20210206","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ibd.20028","article-title":"Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease","volume":"13","author":"Morales","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R22-9-20210206","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2007.03301.x","article-title":"Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease","volume":"25","author":"Winter","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32830d3aaf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:21Z","timestamp":1786036041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200810000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32830d3aaf","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}